| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Niven Ralph is a Chief Scientific Officer at JBIO. Recent filings cover 0 purchases and 25 sales. Those positions are worth an estimated $13K at current prices.
Our model assigns Niven Ralph a strong insider score of 74/100, based on 16 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +33.7%.
Niven Ralph's largest disclosed position is in JBIO as Chief Scientific Officer, worth about $13K. The recent filings there lean toward selling, a net 54,600 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $26.40 | $59,404.50 | -58.3% | -31.0% | -27.0% | |
| Dec 5, 2022 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $17.38 | $39,114.00 | -58.3% | +32.8% | -10.4% | |
| Nov 7, 2022 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $19.20 | $43,194.40 | -58.3% | +40.0% | -31.5% | |
| Oct 5, 2022 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $15.75 | $35,446.59 | -58.3% | +63.9% | -17.3% | |
| Sep 6, 2022 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $19.00 | $42,750.00 | -58.3% | +1.1% | -15.7% | |
| Aug 18, 2022 | JBIO Jade Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 2,250 | $21.18 | $47,657.25 | -58.3% | -9.9% | -34.3% |